Pravin Chaturvedi

Dr. Chaturvedi is the Chairman of Boston-based IndUS Pharmaceuticals and a co-founder and CEO of Florida-based Oceanyx Pharmaceuticals. He also serves as the Chairman of the Scientific Advisory Board (SAB) and Chief Scientific Officer of San Francisco-based Napo Pharmaceuticals and Jaguar Health. Previously he has served as the President and Chief Executive Officer of Boston-based Scion Pharmaceuticals and serves on the boards of IndUS, Oceanyx, Cellanyx, ResoluteBio, Enlivity and Sindu Research Laboratories. He has previously served on the boards of Scion Pharmaceuticals, FuelEd Schools, PRADAN USA, and TiE Boston. He also serves on several advisory boards and is an adjunct faculty member at Georgetown Medical School. Over his 25+ year career, Dr. Chaturvedi has participated in drug development and commercialization activities for several novel drugs. Prior to his leadership and governance roles, Dr. Chaturvedi, spent several years at Vertex Pharmaceuticals as the Head of Lead Evaluation. Prior to his role at Vertex, he was in the preclinical group at Alkermes and he started his R&D career in the Product Development group at Parke-Davis/Warner-Lambert Company (now Pfizer). Dr. Chaturvedi holds a Ph.D. in Pharmaceutical Sciences from West Virginia University and a Bachelor’s in Pharmacy from the University of Bombay.